VRX may have accounting issues and getting sloppy buy of Sprout drug for $1 billion. Debt is 30 billion sales 10 billion is high. PTX has about $200 million notes and $100 convertible. Zohydro should pick up in coming quarters like you mentioned. We may see slightly better sales #s than expected.